NCT02784171 2024-12-10
Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma
Canadian Cancer Trials Group
Phase 2/3 Completed
Clinical Trials
11 trialsNCT02337530 2024-03-21
Selumetinib in Patients Receiving Pemetrexed and Platinum-based Chemotherapy in Advanced or Metastatic KRAS Wildtype or Unknown Non-Squamous NSCLC
Canadian Cancer Trials Group
Phase 2 Completed
NCT01708993 2023-08-04
Reolysin in Previously Treated Advanced/Metastatic, Non Small Cell Lung Cancer Receiving Standard Salvage Therapy
Canadian Cancer Trials Group
Phase 2 Completed
NCT01783197 2023-08-04
Study of Selumetinib in Patients With Previously Treated or Untreated Advanced/Metastatic NSCLC
Canadian Cancer Trials Group
Phase 1 Completed
NCT00101283 2023-07-03
Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT00691301 2018-01-09
Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
GOG Foundation
Phase 2 Completed
NCT01700400 2014-11-24
Study of Everolimus, Pemetrexed, Carboplatin, and Bevacizumab to Treat Stage IV Lung Cancer
Cancer Research and Biostatistics Clinical Trials Consortium
Phase 1 Completed
NCT00070473 2014-02-20
Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors
Children's Oncology Group
Phase 1 Completed
NCT00087113 2014-02-14
Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix
GOG Foundation
Phase 2 Completed
NCT00227630 2012-07-18
Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT00107419 2012-01-18
S0423 Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable or Metastatic Chondrosarcoma
SWOG Cancer Research Network
Phase 2 Completed